Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




BioConference Live to Focus on Clinical Diagnostics

By LabMedica International staff writers
Posted on 04 Oct 2010
BioConference Live offers the benefits of a conventional conference, with live keynote presentations, peer networking and an exhibit floor--over the web, so that attendees can participate from any computer, whether in their office, home, or teaching institution.

The upcoming edition of BioConference Live with its focus on clinical diagnostics will take place from 9:00 AM to 6:00 PM [U.S. More...
EDT] on Wednesday October 20, 2010, and on Thursday October 21, 2010.

On Wednesday, October 20, 2010, at 12:00 noon EDT, Alan Wu Ph.D., chief of clinical chemistry and toxicology and professor of laboratory medicine at San Francisco General Hospital (CA, USA) and University of California, San Francisco (CA, USA) will speak about the emerging role of pharmacogenomics in clinical research and practice. On the same day at 4: PM EDT Gyorgy Abel M.D. Ph.D., director of clinical immunology and molecular diagnostics at Harvard Medical School (Boston, MA, USA) will talk about human papillomavirus (HPV) molecular testing in cervical cancer screening.

On the following day, Thursday October 21st, 2010, at 9 AM James Nichols Ph.D., DABCC, FACB, medical director of clinical chemistry at Baystate Health (Springfield, MA, USA) and professor of pathology at Tufts University School of Medicine (Boston, MA. USA) will discuss point-of-care testing, what it is, and why everyone wants it. Later on Thursday, at 4:00 PM EDT Keith C. Ferdinand, M.D., FACC, FAHA, will talk about strategies for the management of hypertension. Dr. Ferdinand is the adjunct professor at Morehouse School of Medicine (Atlanta, GA, USA), and clinical professor, cardiology division at Emory University (Atlanta, GA, USA). He is also Chief Science Officer (CSO) for the Association of Black Cardiologists (ABC; Washington DC, USA).

An additional twenty speakers have been confirmed to participate in the BioConference Live program. To register to attend for free and to obtain a complete list of speakers and session topics visit BioConference Live (please see related links below).

The supporters of BioConference Live are Bio-Rad Laboratories (Hercules, CA, USA), Thermo Fisher Scientific (Waltham, MA, USA), the Ortho Clinical Diagnostics (Rochester, NY, USA) division of Johnson & Johnson, and Randox Laboratories (Antrim, UK).

The event producers are PlatformQ (Needham, MA, USA), a digital media company that produces virtual events in the education and healthcare markets, and Labroots, Inc., a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other.

Related Links:
BioConference Live


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.